OTC/SmallCap IRW

Fosun International's total revenue in 2022 amounted to RMB175.39 Billion, up 8.7% Year-on-year

HONG KONG, March 30, 2023 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today announced its annual results for the year ended 31 December 2022 (the "Reporting Period"). In 2022, the increasingl...

2023-03-30 21:55 2445

THE 2023 CEO & CMO SUMMIT IN VIETNAM: A WORLD-CLASS CONFERENCE FOR BRANDS

HO CHI MINH CITY, Vietnam, March 30, 2023 /PRNewswire/ -- The CEO & CMO Summit 2023 by MMA Global inVietnam brings together senior executives, marketing directors, and industry experts from multinational organizations, firms, and startups. The CEO & CMO Summit Vietnam conference has consolidated...

2023-03-30 16:44 2046

Fosun International: Focused Strategy to Empower the Sustainable Growth, Total Revenue up 8.7% YoY to RMB175.39 Billion in 2022

2022 Annual Results Highlights: * Total revenue for the year amounted to RMB175.39 billion, representing a year-on-year increase of 8.7% * Overseas revenue for the year amounted to RMB77.4 billion, representing a year-on-year increase of 14% and accounting for 44% of the total revenue; enter...

2023-03-29 22:07 2982

Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV

Tavneos® newly introduced in the 2022 European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of ANCA-associated vasculitis (AAV) Recommendations recognize Tavneos®' ability to induce and sustain remission, lower glucocorticoids-induced toxic effects and pot...

2023-03-28 13:00 2065

VECTION TECHNOLOGIES AND EXPERT.AI TEAM UP TO DIGITIZE TECHNICAL MANUALS WITH AI

PERTH, Australia, March 28, 2023 /PRNewswire/ -- Vection Technologies (ASX:VR1, OTC:VCTNY), the INTEGRATEDXR® company, and expert.ai (EXAI:IM), a leading company in artificial intelligence (AI) for language understanding and language operations, announce today a partnership to create an AI-powere...

2023-03-28 06:30 2055

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS for adult and pediatric patients 12 years of age and older Joenja® is expected to launch in the US in early April Pharming will host a con...

2023-03-25 02:51 7423

Elkem ASA - Annual report for 2022

OSLO, Norway, March 21, 2023 /PRNewswire/ -- Elkem ASA has today published its annual report, including the ESG report, for the financial year ended31 December 2022. In his letter to shareholders, Elkem's CEO Helge Aasen writes: "Elkem continued to benefit from exceptionally strong markets in 20...

2023-03-21 16:22 1668

Guo Guangchang Stresses Healthy Corporate Development and Expresses Full Confidence in the Future

HONG KONG, March 20, 2023 /PRNewswire/ -- On 17 and 18 March, Guo Guangchang, Chairman of Fosun International, attended the 23rd Annual Conference of Yabuli China Entrepreneurs Forum 2023, and the 6th Shanghai Forum Themed Zhejiang Entrepreneurs in the World & the 11th Member Representative Confe...

2023-03-20 17:12 2172

SEVERAL PATENTS GRANTED ACROSS THE US AND THE EU, STRENGHTENING THE INTEGRATEDXR® IP

PERTH, Australia, March 20, 2023 /PRNewswire/ -- Vection Technologies, the INTEGRATEDXR® company, announces several patents granted across the US and Europe related to its INTEGRATEDXR® technology stack. The United States Patent Office (USPTO) has issued patent number 11,398,082 entitled "Affine...

2023-03-20 07:41 2255

Ericsson Annual Report on Form 20-F filed with the SEC

STOCKHOLM, Sweden, March 16, 2023 /PRNewswire/ -- On March 15, 2023, Ericsson (NASDAQ:ERIC) filed its Annual Report on Form 20-F for the year endedDecember 31, 2022, with the U.S. Securities and Exchange Commission (SEC). The Annual Report is available on Ericsson's website at https://www.ericss...

2023-03-16 05:39 3012

Mycronic receives order for an SLX mask writer

STOCKHOLM, March 15, 2023 /PRNewswire/ -- Mycronic AB (publ) has received an order for an SLX mask writer from an existing customer inAsia. The order value is in the range ofUSD 5-7 million. Delivery of the system is planned for the fourth quarter of 2023. The SLX laser mask writer meets rising ...

2023-03-15 15:58 1734

Mycronic receives order for a Prexision 8 Evo and an FPS 6100

STOCKHOLM, March 14, 2023 /PRNewswire/ -- Mycronic AB (publ) has received an order for a Prexision 8 Evo and an FPS 6100 from an existing customer inAsia. The order value is in the range ofUSD 25-28 million. Delivery of the Prexision 8 Evo is planned for the fourth quarter of 2023, while the FPS ...

2023-03-14 16:09 1357

Music Licensing, Inc. (OTC:SONG) and Pro Music Rights, Inc. Announce No Direct or Known Exposure to Silicon Valley Bank Collapse

NAPLES, Fla., March 13, 2023 /PRNewswire/ -- Music Licensing, Inc. (OTC:SONG) and its wholly owned subsidiary, Pro Music Rights, Inc., announced today that the companies have no direct or known exposure to the collapse of Silicon Valley Bank. This announcement comes as a reassurance to Music Lice...

2023-03-13 10:01 2068

Hong Kong Fintech start-up On-us launches zero-waste voucher solution as event engagement tool to eliminate waste and promote sustainability

HONG KONG, TAIPEI and SINGAPORE, March 7, 2023 /PRNewswire/ -- On-us Company Limited ("On-us" or the "Company") is proud to announce the launch of its innovative zero-waste event engagement solution aiming to drive participation and foster connections among communities, promoting sustainability a...

2023-03-07 13:49 2973

Music Licensing, Inc.'s Subsidiary Pro Music Rights Renews Agreement with ByteDance and TikTok, Offering Innovative Music and AI Solutions

NAPLES, Fla., March 3, 2023 /PRNewswire/ -- Music Licensing, Inc. (OTC:SONG) is thrilled to announce that its wholly-owned subsidiary Pro Music Rights, Inc. has renewed its licensing agreement with ByteDance and its subsidiary TikTok for another year. This milestone marks a significant achievemen...

2023-03-03 22:20 7217

Music Licensing, Inc. Submits Application to Reapply to OTCQB Venture Market

NAPLES, Fla., Feb. 24, 2023 /PRNewswire/ -- Music Licensing, Inc. (OTC:SONG) has submitted its application to reapply to OTCQB, a venture market. The move represents a significant step forward for the company, as it aims to strengthen its position in the music licensing industry. "We are thrille...

2023-02-24 22:25 6577

SMARTKEM JOINS HI-ACCµRACY PROJECT DEVELOPING ACTIVE-MATRIX PRINTED Q-LED DISPLAYS

EUROPEAN COLLABORATION AIMS TO REVOLUTIONISE DISPLAY PRODUCTION TECHNOLOGY MANCHESTER, England, Feb. 23, 2023 /PRNewswire/ -- SmartKem, Inc. (OTCQB: SMTK), a company seeking to reshape the world of electronics with a revolutionary semiconductor platform that enables a new generation of displays, ...

2023-02-23 23:30 3480

DSM And Firmenich Have Obtained Competition Clearance from the European Commission

This is a joint press release by Koninklijke DSM N.V. (DSM), Firmenich International SA (Firmenich) and Danube AG, to be renamed DSM-Firmenich AG (the Company) in connection with the voluntary public exchange offer by the Company for all the issued and outstanding ordinary shares in the share cap...

2023-02-23 14:00 1687

Music Licensing, Inc. (OTC: SONG) Seeks to Reapply to OTCQB and Apply to International Stock Exchanges

NAPLES, Fla., Feb. 21, 2023 /PRNewswire/ -- Music Licensing, Inc. (OTC: SONG), a leading provider of music licensing, Artificial Intelligence (A.I.), & copyright solutions, is pleased to announce its plans to reapply to OTCQB and apply to other international stock exchanges around the world. The...

2023-02-21 22:00 3047

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR) announces t...

2023-02-21 14:00 2918
1 ... 9101112131415 ... 55